COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
Favaloro EJ;Henry BM;Lippi G;;
seminars in thrombosis and hemostasis2021pp. -
111
ej2021seminarscovid-19
Abstract
Antiphospholipid antibodies (aPL) comprise a panel of autoantibodies that reflect a potential prothrombotic risk in several autoimmune conditions, most notably antiphospholipid (antibody) syndrome (APS). aPL can be divided into those that form part of the laboratory criteria for APS, namely, lupus a …